Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.
Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- Check7 days agoChange Detected- Removed related topics: 'Multiple myeloma' and 'MedlinePlus Genetics' from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check14 days agoChange DetectedLocations section now lists New Jersey as the study site. HHS Vulnerability Disclosure link removed and page revision updated to v3.3.3.SummaryDifference0.2%
- Check21 days agoChange DetectedAdded related topics: "Multiple myeloma" and "MedlinePlus Genetics" to the Related Topics section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check28 days agoChange DetectedDifference0.1%
- Check35 days agoChange DetectedAdded related topic tags: 'Multiple myeloma' and 'MedlinePlus Genetics' to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check42 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2; no study content or layout changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.